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Abstract
Objectives Our aim was to evaluate the quality of published
guidelines on musculoskeletal ultrasound (MSK-US) for
adults.
Methods Between June and July 2016, we conducted an on-
line search for MSK-US guidelines, which were evaluated by
four independent readers blinded to each other using the
AGREE II tool. A fifth independent reviewer calculated
scores per each domain and agreement between reviewers’
scores using the intraclass correlation coefficient (ICC).
Results Fiveguidelineswereincludedinthisappraisal.Theywere
publishedbetween2001and2014.Ourappraisal showedinterme-
diate results, with four out of five guidelines scoring “average” as
overallquality.Domain1(scopeandpurpose)achievedthehighest
result (total score=71.1%±18.7%).Domain6 (editorial indepen-
dence) had the lowest score (total score = 26.3% ± 19.3%).
Interobserveragreementwasverygoodforall theevaluatedguide-
lines (ICC ranged between 0.932 and 0.956).
Conclusions Overall, quality of MSK-US guidelines ranges
from low to average when evaluated using the AGREE II tool.
The editorial independence domain was the most critical, thus
deserving more attention when developing future guidelines.
Main messages
• Four of five guidelines on MSK-US had an average quality
level.
• Scope/purpose had the highest score (71.1% ± 18.7%).
• Edi tor ia l independence had the lowes t score
(26.3% ± 19.3%).
• Interobserver agreement was very good (ranges: 0.932–
0.956).
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Introduction
Ultrasound (US) is currently considered the preferred first-line
imaging modality for investigating several musculoskeletal
disorders [1, 2]. Recent improvements in US technology has
resulted in an increased diagnostic accuracy for a wide spec-
trum ofmusculoskeletal diseases affecting tendons, ligaments,
muscles, and nerves both at upper and lower limbs [1, 3–7].
Further advantages of US are, among others, its non-invasive-
ness, being in particular a radiation-free modality, as well as
the wide availability of US systems and low cost [8, 9]. For
these reasons, the use of musculoskeletal US (MSK-US) is
rapidly increasing among physicians worldwide [1].
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At the same time, the widespread use of MSK-US has
raised the need for “evidence-based” recommendations to
help physicians in choosing when US is more indicated in
the daily routine and how to perform a technically correct
US examination. In fact, appropriate use of US examinations
is fundamental for increasing the diagnostic accuracy as well
as to reduce the number of unnecessary examinations [1, 10].
For these reasons, some guidelines have been developed in
recent years with recommendations that include indications
for MSK-US examination, which anatomical part or structure
to evaluate, or the most relevant clinical conditions for which
MSK-US is indicated [1, 11–14]. Such guidelines are usually
developed by medical bodies or specialised working groups
and play a key role in clinical practice and are a reference in
the case of malpractice case litigation [10], as they should
provide indications based on the highest level of evidence.
This evidence is usually achieved by critical selection and
evaluation of systematically searched original studies and
meta-analyses [15, 16]. However, according to the methodol-
ogy of guideline development, variation in quality may occur.
Thus, it is crucial to evaluate the methods on which a guide-
line is developed [17, 18].
Different quality appraisal tools have been developed for
the evaluation of guidelines. Among them, the Appraisal of
Guidelines for Research & Evaluation version II (AGREE II)
has been reported to be a reliable, internationally used, and
validated tool [19].
The European Network for the Assessment of Imaging in
Medicine (EuroAIM), a joint initiative of European Institute
for Biomedical Imaging Research, was initiated with the aim
to increase the evidence for the rational use of medical imag-
ing [15, 20]. Recently, EuroAIM has been focusing its activity
on the evaluation of guidelines in different fields of diagnostic
imaging [21]. For what concerns musculoskeletal radiology, a
conjoined project between EuroAIM and the European
Society of Musculoskeletal Radiology (ESSR) was
established [21], and MSK-US was included among the topic
of interests.
The aim of this study was to evaluate the quality of current
guidelines onMSK-US for adults using the AGREE II quality
assessment tool.
Materials and methods
Between June and July 2016, we performed a literature search
for MSK-US guidelines using PubMed, EMBASE, Google,
and the Wiley Online Library, with the following keywords:
“musculoskeletal ultrasound”, “musculoskeletal ultrasonogra-
phy”, “Guidelines”, “Indications”, “Official Positions” and
their expansions. Once guidelines were retrieved, their refer-
ences were screened for further papers to include. We exclud-
ed from the results of our search those papers that were not
primarily focused on MSK-US, such as guidelines about im-
aging of specific disorders in which US was described in the
setting of a more comprehensive evaluation. Inclusion criteria
were as follows: full manuscript available in English; guide-
lines issued by national or international medical bodies; guide-
lines mainly focused on the evaluation of musculoskeletal
disorders by means of US; guidelines might contain recom-
mendation on the MSK-US anatomy technique; guidelines
must focus mainly on the adult population (age > 18 years).
Guideline quality evaluation was made using the AGREE II
instrumentvia theofficialwebsitededicatedonlineplatform[19].
TheAGREEIIprotocol consistof23different itemsorganised in
6domains:domain1=“ScopeandPurpose” (items1–3);domain
2 = “Stakeholder Involvement” (items 4–6); domain 3 = “Rigor
of Development” (items 7–14); domain 4 = “Clarity of
Presentation” (items 15–17); domain 5 = “Applicability” (items
18–21); domain 6 = “Editorial Independence”. These six do-
mains are followed by two additional items (“Overall
Assessment”), which includes “the rating of the overall quality
of theguidelineandwhether theguidelinewouldberecommend-
ed for use in practice”. Table 1 shows a detailed description of all
AGREE II items [19].
Four independent reviewers (CM, BB, DO, AC) with 4 to
14 years’ experience in MSK-US and scientific research gave
a score to each guideline. Reviewers were selected by the
EuroAIM working group among the members of the US sub-
committee of the ESSR. All reviewers were previously trained
to use the AGREE II scoring system through the user manual,
which is available on the online platform; in addition, re-
viewers were asked to complete two online training tools spe-
cifically developed to assist users in effectively applying the
instrument. According to the instruction tool, each item was
rated on a 7-point scale, which ranges from 1 (strongly dis-
agree, which means that no relevant information is provided)
to 7 (strongly agree, which means that the quality of reporting
is exceptional). Final domain scores were calculated by sum-
ming up scores of all items within the domain and by scaling
the total as a percentage of the maximum possible score for
that domain [available via http://www.agreetrust.org/about-
the-agree-enterprise/introduction-to-agree-ii/scoring-the-
agree-ii/].
Data analysis
For analysis purposes, the evaluations performed by each re-
viewer were averaged; the average of each domain is reported
in the results. Agreement between reviewers’ scores was cal-
culated using the intraclass correlation coefficient (ICC), de-
fined as follows: <0.20, poor; 0.21–0.40, fair; 0.41–0.60,
moderate; 0.61–0.80, good; 0.81–1.00, very good. As for pre-
vious studies, the overall quality of each guidelines was eval-
uated using a threshold of 60% for the final score of each
domain [22, 23]. High quality was defined when 5 or more
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domains scored >60%, average quality when 3 or 4 domains
scored >60%, low quality when ≤2 domains scored >60%. In
addition, the total score (expressed as mean ± standard devia-
tion, SD) of guidelines and domains was calculated. Domain
scores were categorised as good (≥ 80%), acceptable (60–
79,9%), low (40–59,9%), or very low (<40%), similar to a
previous similar paper [24]. Data extraction, collection, and
scoring were done by a fifth independent reviewer (LMS) with
14 years of experience in musculoskeletal US and scientific
research, using a Microsoft Excel® 2016 spreadsheet. ICC
calculations were performed using the SPSS software (version
24, IBM, Armonk, NY, USA).
Results
Our strategyof literature search identified206papers, 5ofwhich
metour inclusioncriteria [1,11–14].ThecharacteristicsofMSK-
US guidelines that were included in our study are presented in
Table 2. Year of publication ranged from 2001 to 2014.
Table 3 summarises the total score for each domain as well
as the final judgment of overall quality. Detailed scores and
reviewers’ comments for each guideline are reported in
Supplementary Tables 1 to 5. Four out of five guidelines
reached an average level of quality, having 3 or 4 domains
with a score higher than 60%. Among these, “Clinical indica-
tions for musculoskeletal ultrasound” by Klauser et al. [1] on
behalf of the ESSR achieved the highest total score (66.2%).
Only the “Guidelines for musculoskeletal ultrasound in rheu-
matology” by Backaus et al. [14] on behalf of EULAR had a
low level of quality, with only two domains scoring >60% and
a total score of 35.9% ± 20.6%. The paper “Musculoskeletal
ultrasound: technical guidelines” by Martinoli [11] on behalf
of the ESSRwas the guideline with the greatest score variabil-
ity, with a SD of 29.7%, while the rheumatologic guideline
issued by EULAR [14] had the lowest variability
(SD = 20.6%).
Table 1 Summary of AGREE II structure and detailed list of items within each domain (from reference 15)
Domain 1. Scope and purpose
Item 1 The overall objective(s) of the guideline is (are) specifically described
Item 2 The health question(s) covered by the guideline is (are) specifically described
Item 3 The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described.
Domain 2: Stakeholder involvement
Item 4 The guideline development group includes individuals from all the relevant professional groups.
Item 5 The views and preferences of the target population (patients, public, etc.) have been sought.
Item 6 The target users of the guideline are clearly defined.
Domain 3: Rigor of development
Item 7 Systematic methods were used to search for evidence.
Item 8 The criteria for selecting the evidence are clearly described.
Item 9 The strengths and limitations of the body of evidence are clearly described.
Item 10 The methods for formulating the recommendations are clearly described.
Item 11 The health benefits, side effects, and risks have been considered in formulating the recommendations.
Item 12 There is an explicit link between the recommendations and the supporting evidence.
Item 13 The guideline has been externally reviewed by experts prior to its publication.
Item 14 A procedure for updating the guideline is provided.
Domain 4: Clarity of presentation
Item 15 The recommendations are specific and unambiguous.
Item 16 The different options for management of the condition or health issue are clearly presented.
Item 17 Key recommendations are easily identifiable.
Domain 5: Applicability
Item 18 The guideline describes facilitators and barriers to its application.
Item 19 The guideline provides advice and/or tools on how the recommendations can be put into practice.
Item 20 The potential resource implications of applying the recommendations have been considered.
Item 21 The guideline presents monitoring and/or auditing criteria.
Domain 6: Editorial independence
Item 22 The views of the funding body have not influenced the content of the guideline.
Item 23 Competing interests of guideline development group members have been recorded and addressed.
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Domain scores ranged between 8.3% (lowest value, do-
main 6 of EULARGuidelines [14]) and 87.5% (highest value,
domain 1 of ESSR “Clinical Indications for Musculoskeletal
Ultrasound” [1]). When comparing the scores of each domain
across guidelines, “Clarity of Presentations” (domain 4) and
“Scope and Purpose” (domain 1) achieved the highest results,
with a total domain score of 73.9% ± 11.2% and
71.1% ± 18.7%, respectively. The domain with the lowest
total score was “Editorial Independence” (domain 6), with a
total mean score of 26.3% ± 19.3%.
Total mean score of domain 1 (“Scope and Purpose”) was
71.1% with moderate variability (SD = 18.7%). The ESSR
“Clinical Indications for Musculoskeletal Ultrasound” [1]
reached the highest score (87.5% = good), while the
EULAR guidelines [14] had a “very low” score of 38.9%.
Total mean score of domain 2 (“Stakeholder Involvement”)
was 57.5% with the lowest variability (SD = 9.1%). Within
this domain, AIUM guidelines [12] had the highest score
(63.9% = acceptable), while the EULAR guidelines [14] had
the lowest score (41.7% = very low).
Domain 3 (“Rigor of Development”) was the one with the
second lowest mean score (32.7%) and, overall, the higher
variability (SD = 25.5%). This variability is related to the
considerable difference between the guideline with the highest
domain score (ESSR “Clinical Indication for Musculoskeletal
Ultrasound” [1], total score of 74.5%) and the technical guide-
line by Martinoli [11], of which the final domain score was
9.9% (“very low”).
For domain 4 (“Clarity of Presentation”), the overall mean
score was “acceptable” with a mean score of 73.9%. Quality
scores variability was 3.6% SD. The ESSR “Clinical indica-
tions for musculoskeletal ultrasound” [1] was the guideline
with the highest score (87.5% = good), while the EULAR
guidelines [14] scored the lowest value (61.1% = acceptable).
Domain 5 (“Applicability”) had a mean quality score of
46.3% with moderate variability (SD = 9.3%). Guideline
scores varied from the maximum value of 63.5%
(acceptable) from the ACR–AIUM–SPR–SRU [13] con-
joined guideline to the lowest value of 30.2% (very low) of
the technical guideline by Martinoli [11].
Overall, the domain with the lowest score was domain 6
(“Editorial Independence”), with a mean score of 26.3%. This
domain had the second larger variability, with a SD of almost
20%. As for the other domains, this variability is influenced
by the difference between the highest and lowest domain
score. The ESSR “Clinical indications for musculoskeletal
ultrasound” [1] had the highest value of 58.3%, still consid-
ered “low”. Conversely, EULAR guidelines [14] reached the
score of 8.3% (very low), which was the lowest value among
all domains.
Interobserver variability ranges were 0.956 (very good;
95% confidence interval, 0.917–0.979) for the ESSR
“Musculoskeletal ultrasound: technical guidelines” [11];
0.932 (very good; −0.872-0.968) for ESSR “Clinical indica-
tions for musculoskeletal ultrasound” [1]; 0.936 (very good;
−0.879-0.970) for EULAR guidelines [14]; 0.944 (very good;
−0.895-0.974) for AIUM guidelines [12]; and 0.941 (very
good, −0.889-0.972) for the ACR–AIUM–SPR–SRU con-
joined guidelines [13].
Discussion
Our main finding is that the AGREE II appraisal of MSK-US
guidelines showed intermediate results, with an overall quality
that was “average” in four out of five guidelines and many
domains that scored “low” or “very low”. In addition, even
though a high variability was found across the six domains, a
Table 2 General characteristics of MSK-US guidelines included in the analysis
MSK-US guideline title Country
of origin
Year of
publication
Organization
Musculoskeletal ultrasound:
technical guidelines [11]
European Union 2010 European Society of Musculoskeletal
Radiology (ESSR)
Clinical indications for musculoskeletal
ultrasound: a Delphi-based consensus
paper of the European Society of
Musculoskeletal Radiology [1]
European Union 2012 European Society of Musculoskeletal
Radiology (ESSR)
Guidelines for musculoskeletal ultrasound
in rheumatology [14]
European Union 2001 European League Against Rheumatism
(EULAR) Working Group for MSK-US
AIUM Practice Parameter for the Performance of a
MSK US Examination [12]
USA 2012 American Institute of Ultrasound in
Medicine (AIUM)
ACR–AIUM–SPR–SRU Practice Parameter for
the Performance of the Musculoskeletal
Ultrasound Examination [13]
USA 2014 American College of Radiology (ACR),
American Institute of Ultrasound in
Medicine (AIUM), Society for Pediatric
Radiology (SPR), Society of Radiologists
in Ultrasound (SRU)
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“good” domain score (i.e. a percentage higher than 80%) was
reached only three times. When considering the within-
domain scores, variability was somehow smaller, with domain
2 (stakeholder involvement) showing the lowest SD.
One of the reasons for these results may be that four guide-
lines [11–14] are mainly technical guidelines, dealing mostly
or only with the practical execution ofMSK-US examinations
(e.g., how to orient the probe, position the patient, visualise a
tendon). Therefore, their purpose is to provide technical edu-
cation rather than literature evidence on the topic. In this set-
ting, not all domains evaluated by the AGREE II tool may be
relevant to this kind of recommendation. Nevertheless,
AGREE II developers clearly state that this tool “can be ap-
plied to guidelines in any disease area targeting any step in the
health care continuum”, therefore opening the possibility to
technical guidelines appraisal as well. Of note, the ESSR
“Clinical indications for musculoskeletal ultrasound” [1] is a
guideline based on a Delphi process which occurred after a
thorough review of pertinent literature and was aimed to pro-
vide clinical indications about the degree of evidence of the
use of MSK-US in different parts of the body. This may ex-
plain why this guideline was the one with the highest overall
score. However, excluding technical guidelines, we acknowl-
edge a relative low number of clinical guidelines onMSK-US.
Domains with the highest quality were “clarity of presenta-
tion” (domain 4) and “scope and purpose” (domain 1), as both
scored over 70%. Although less evident in our appraisal, this is
comparable to previous papers that evaluated other guideline
with the AGREE II tool, regardless of the topic [23–26]. The
reason of such high specific domain scores is still unclear [23].
A possible explanation may be the fact that domains 1 and 4
contain fundamental guideline parts that cannot be easily omit-
ted, such as the objectives, the health question being addressed,
andthepopulation towhomtheguideline isapplied.Thus,guide-
line developers probably paymore attention to these parts when
developing their papers.
Editorial independence (domain 6) scored “very low” in all
guidelines, except for the paper ESSR “Clinical indications
for musculoskeletal ultrasound”, whose final score was
“low”. Therefore, this was the domain with the poorest score
(26.3%). A similar situation was reported by Armstrong et al.
in a recent appraisal of osteoporosis guidelines, with domain 6
presenting with the lowest score (45%) [23]. The score of this
domain was low in several other studies [24, 25, 27, 28], with
few exceptions [26]. Regarding “Editorial Independence”
evaluation, the AGREE II considers two items related to
funding bodies or potential authors’ competing interests that
may have influenced the guideline content [19]. To accom-
plish AGREE II criteria, an explicit statement that the funding
body interests have not influenced the final recommendations
should be present; at the same time, all guideline authors
should provide a disclosure of all competing interests.
According to reviewers, this information is not adequatelyTa
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reported in all guidelines, especially for the EULAR paper,
which obtained a score lower than 10%. This aspect remains
critical, as it has been shown that conflicts of interest among
authors of guidelines are very common and may affect the
quality of final recommendations [23, 29–31]. Therefore, par-
ticular attention to the quality of this domain is obviously
needed, especially for those guidelines containing recommen-
dation on diagnostic technologies or medications.
According to the AGREE II instrument, a substantial in-
crease in the overall quality score of MSK-US was observed
from 2001 to 2012, but not so from 2012 to 2014. Compared
to EULAR guidelines [14] published in 2001, the paper by
ESSR [1] published in 2012 had an improvement in the final
total score of about 30%.Our results differ from a 2012 review
by Kung et al. [32] who found that very small improvement of
medical guidelines occurred over the previous two decades.
On the other side, a paper published in 2016 by Armstrong
et al. shows similar values of quality improvement over time
[23]. However, the number of guidelines evaluated is relative-
ly low, so that more time is necessary to confirm this trend.
Importantly, interobserveragreementwasverygoodforall the
evaluated guidelines; hence, all reviewerswere quite unanimous
about the conferred scores. In fact, all reviewers’ commentswere
somehow uniform, a finding that further confirm the reviewers’
confidence with the AGREE II appraisal system.
This study has limitations, some of them being intrinsic to
the AGREE II system. In fact, this tool is not aimed at evalu-
ating all aspects of a guideline. First, AGREE II does not
evaluate the degree of consistency between guideline recom-
mendation and the reported evidence [24]. Also, AGREE II
does not evaluate the scientific and clinical content, a limita-
tion that is common to several appraisal tools [33]. Finally, the
four reviewers of this appraisal have different experiences in
MSK-US and guidelines evaluation, potentially biasing the
outcome. However, the use of average scores and previous
training on the proper of AGREE II instrument should have
reduced the impact of this limitation.
In conclusion, our study showed that overall quality of
MSK-US guidelines is intermediate according to the
AGREE II evaluation. Domain 6 (Editorial Independence)
was the most critical considering the overall score; therefore,
emphasis should be given to these aspects, to produce recom-
mendations with a lower risk of bias.
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